This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yuting Cai - Innovator in Small Molecule Compounds
Introduction
Yuting Cai is a notable inventor based in Zhejiang, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. Her work focuses on creating innovative solutions for medical applications.
Latest Patents
Yuting Cai holds a patent for a small molecule compound that serves as a highly efficient and specific JAK kinase inhibitor. This compound is characterized by its various forms, including stereoisomers, geometric isomers, tautomers, racemates, hydrates, solvates, metabolites, and pharmaceutically acceptable salts or prodrugs. The compound is particularly effective as a Tyk2 inhibitor and/or a JAK1 inhibitor, and/or a JAK1/Tyk2 dual inhibitor.
Career Highlights
Yuting Cai is currently associated with Technoderma Medicines Pte Ltd., where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key player in the pharmaceutical industry.
Collaborations
Yuting collaborates with talented individuals such as Xiang Pan and Yang Wang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yuting Cai's work in small molecule compounds exemplifies the impact of innovative research in the pharmaceutical field. Her contributions are paving the way for new therapeutic options and enhancing the understanding of JAK kinase inhibitors.